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Saudi ArabiaAbstract Papillon–Lefevre syndrome (PALS) is a rare, autosomal recessive disorder characterized
by periodontitis and hyperkeratosis over the palms and soles. Mutations in the cathepsin C gene
(CTSC) have been recognized as the cause of PALS since the late 1990s. More than 75 mutations
in CTSC have been identiﬁed, and phenotypic variability between different mutations has been
described. Next generation sequencing is widely used for efﬁcient molecular diagnostics in various
clinical practices. Here we investigated a large consanguineous Saudi family with four affected and
four unaffected individuals. All of the affected individuals suffered from hyperkeratosis over theiversity,
572 Y.M. Alkhiary et al.palms and soles and had anomalies of both primary and secondary dentition. For molecular
diagnostics, we combined whole-exome sequencing and genome-wide homozygosity mapping pro-
cedures, and identiﬁed a recurrent homozygous missense mutation (c.899G>A; p.Gly300Asp) in
exon 7 of CTSC. Validation of all eight family members by Sanger sequencing conﬁrmed
co-segregation of the pathogenic variant (c.899G>A) with the disease phenotype. This is the ﬁrst
report of whole-exome sequencing performed for molecular diagnosis of PALS in Saudi Arabia.
Our ﬁndings provide further insights into the genotype–phenotype correlation of CTSC pathogenic-
ity in PALS.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Papillon–Lefevre syndrome (PALS, MIM 245000) is a rare,
autosomal recessive genodermatosis. The disease was ﬁrst
described by two French scientists, Papillon and Lefevre, in
1924 (Papillon and Lefevre, 1924). It mainly affects skin and
teeth, leading to hyperkeratoderma over the palms and soles,
also known as palmoplantar hyperkeratosis, and premature
loss of primary or secondary dentition (Haneke, 1979;
Papillon and Lefevre, 1924). Hyperkeratosis ﬁrst appears in
the early stages of childhood (prior to age 3–4); however,
late-onset alterations have also been reported (Pilger et al.,
2003). In general, hyperkeratotic features are not severe in
PALS, and as reviewed recently, the diffuse type is more com-
mon than the punctuate type in most cases (Nagy et al.,
2014). Lesions over the elbow, knee, and knuckles resembling
psoriasis may also develop in some cases (Toomes et al.,
1999). Recurrent mild pus-generating skin infections with self-
healing are also observed (Gorlin et al., 1964; Haneke, 1979).
Periodontitis and gingivitis are associated with both primary
and secondary dental anomalies, and appear at the time of the
two episodes of tooth eruptions: one at 3 years of age and the
second at 15 years old (Fardal et al., 1998; Lundgren and
Renvert, 2004; Toomes et al., 1999). Loss-of-function muta-
tions in the cathepsin C gene (CTSC, MIM 602365), encoding
a lysosomal exo-cysteine proteinase, at 11q14.2 have been
assigned to PALS (Hart et al., 1999; Toomes et al., 1999). To
date, more than 75 pathogenic variants from various ethnic
groups have been identiﬁed as causing PALS and overlapping
phenotypes (Nagy et al., 2014). Haim–Munk syndrome
(HMS, MIM 245010) is characterized by palmoplantar
keratoderma, periodontitis, arachnodactyly, acroosteolysis,
pesplanus, and onychogryposis, and is caused by recessive
mutations in CTSC (Hart et al., 2000b). Similarly, aggressive
periodontitis, which is characterized by severe periodontal
inﬂammation, leading to tooth loss, without the involvement
of skin abnormalities, is another overlapping phenotype of
PALS and is also caused by mutations in CTSC (Hart et al.,
2000c; Hewitt et al., 2004).
Here we present clinical and molecular analysis of a con-
sanguineous ﬁve-generation family from Saudi Arabia segre-
gating an autosomal recessive PALS phenotype.
2. Materials and methods
2.1. Ethical approval
Ethical approval for this study was obtained from the King
Abdulaziz University (KAU), Jeddah, Saudi Arabia (ref #24-14), according to the Helsinki Declaration. The parents of
the affected children signed informed written consent for their
willingness to participate and to publish the results for
academic research purposes.
2.2. Study subjects
The ﬁve-generation family (Fig. 1) resided in a remote
southwestern region of Saudi Arabia. Family information
for the pedigree was obtained by interviewing the parents of
the affected children. All family members, including the
four affected siblings, were thoroughly examined in the
Department of Oral and Maxillofacial Prosthodontics,
Faculty of Dentistry, KAU, Jeddah Saudi Arabia. Venous
blood samples from four affected (V-1, V-2, V-4, V-6) and four
unaffected (III-1, IV-1, V-3, V-5) family members were col-
lected in EDTA tubes, and genomic DNA was extracted and
quantiﬁed using standard methods (Ahmed et al., 2015).
2.3. Homozygosity mapping
Genomic DNA of three affected (V-1, V-2, V-6) and one
unaffected (V-3) individual was subjected to 300 K
HumanCytoSNPs12 microarray analysis using an iScan plat-
form (Illumina, USA) following the manufacturer’s protocols.
The common regions of homozygosity were identiﬁed using
GenomeStudio Genotyping Module v1.0 (Illumina).
2.4. Whole-exome sequencing
Two micrograms of genomic DNA from the index patient
(V-1) were used for human whole-exome analysis with
paired-end-sequencing at 100· resolution. Libraries were con-
structed using a 51-Mb SureSelect library kit (Agilent
Technologies, USA). The target regions with average through-
put depths of more than 120 and100-bp paired-ends reads were
sequenced using a HiSeq2000 platform (Illumina). BWA
(http://bio-bwa.sourceforge.net/) and SAMTOOLS (http://
samtools.sourceforge.net/) were used for alignment of
sequences and copy number variants, and small indel detec-
tion, respectively. The obtained reads were mapped to the
UCSC human genome database hg19 (http://genome.ucsc.
edu/), and were compared with 1000 genomes (http://www.
1000genomes.org/data) and dbSNP (http://www.ncbi.nlm.
nih.gov/snp/) databases. Pathogenicity of the obtained
variants was predicted using LRT (http://www.genetics.wustl.
edu/jﬂab/lrt_query.html), Polyphen-2 (http://genetics.bwh.
harvard.edu/pph2/), SIFT (http://sift.jcvi.org/), MutationTaster
Figure 1 Pedigree analysis of a ﬁve-generation consanguineous family presenting with autosomal recessive inheritance of Papillon–
Lefevre syndrome.
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provean.jcvi.org/genome_submit_2).
2.5. Sanger sequencing
The potential candidate variant was validated by Sanger
sequencing in all eight family members. The CTSC reference
sequence (ENSG00000109861) was obtained from the
Ensembl genome browser (http://www.ensembl.org/Homo_
sapiens/). Primer3Plus (http://www.bioinformatics.nl/) was
used to design the upstream (50-TCAGGGGTAACATGCA
AAGA-30) and downstream (50-TTTGCATGGAGAATCAG
TGC-30) primers for PCR ampliﬁcation of the c.899G>A
region from genomic DNA of each subject. PCR products
were sequenced using a Big Dye Terminator v3.1 Cycle
Sequencing Kit and an ABI 3500 Genetic Analyzer (Life
Technologies, USA). Sequence variants were identiﬁed using
BioEdit sequence alignment editor version 6.0.7 (www.mbio.
ncsu.edu/bioedit.html).
3. Results
3.1. Clinical features
All four affected individuals presented with classical PALS
symptoms, including psoriasiform lesions over knuckles,
hyphidrosis, palmoplantar hyperkeratosis, and periodontal
inﬂammation (Fig. 2). Detailed dental examinations revealed
mild differences among the affected siblings. The index patient
(V-1), a 17-year-old boy, had extensive loss of alveolar bone in
the lower jaw, leading to loss of the lower anterior teeth. The
patient also had generalized severe periodontitis that affected
the secondary dentition, leading to multiple instances of furca-
tion involvement and tooth mobility. Likewise, the periodontal
health of patient V-2, a 15-year-old boy, was affected, with
several instances of grade III furcation involvement and tooth
mobility. The third affected individual (V-4), an 11-year-oldboy, had generalized mild to moderate bone loss that included
furcational involvement of the ﬁrst molars, and again con-
tributed to the loss of multiple teeth. The youngest affected
patient (V-6), a 6-year-old girl, had generalized mild bone loss,
spacing, and crowding in the lower anterior teeth. She had also
mobility in the primary dentition. The hair and nails appeared
normal in all affected individuals, and all were otherwise
healthy without involvement of any of the vital organs. The
unaffected siblings (V-3, V-5) had normal dentition with no
phenotypic indications of PALS, and were clinically indistin-
guishable from healthy individuals.
3.2. Genetic analysis
We combined the results of microarray SNP genotyping with
the whole-exome sequencing data. We found that the three
affected individuals (V-1, V-2, and V-6) shared a common
region of homozygosity, at chromosome 11q13.2–11q23.2
(chr11: 69,953,729–112,031,624 bp); however, it was not
shared by the unaffected individual (V-3). This region
corresponded to a 42-Mb region on human genome Map-
Viewer (annotation release 106; http://www.ncbi.nlm.nih.gov/
mapview/), which contained 518 labeled genes and 670
variants. As the affected individuals were the products of a
consanguineous union, the possibility of homozygous muta-
tion was more likely. We identiﬁed 55 variants for further
investigation after screening all 670 variants using the criteria:
only homozygous single-nucleotide variations (SNV) with
altered nucleotide depth of more than 24, present in the exonic
or splice-site regions, and having non-synonymous, frame-
shift, or stop-gain effects. We further narrowed the list to seven
variants by removing minor allele frequency greater than 0.05.
Of these, three SNVs (XRRA1: NM_182969, c.622G>A,
p.Val208Ile; CTSC: NM_001814, c.899G>A, p.Gly300Asp;
and ELMOD1: NM_001130037, c.952G>A, p.Ala318Thr)
were not reported in the 1000 genome database (Oct. 2011
release) (Supplementary Table 1). Prediction software analyses
Figure 2 Clinical presentation of the affected individuals. The index patient (V-1) showed psoriasiform lesions over the knuckles (A),
hyphidrosis and hyperkeratosis over the palm (B) and sole (C), and periodontal inﬂammation (D and E). Radiological examination of
patients V-1 and V-4 showing extensive loss of the alveolar bone in the lower jaw leading to loss of the lower anterior teeth.
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ﬁrmed the mutation within CTSC as a pathogenic variant.
The mutation was a single nucleotide transition from guanine
to adenine in exon 7 of CTSC at cDNA position 899, leading
to a single amino acid substitution from glycine to aspartate at
amino acid position 300. The obligate carriers were heterozy-
gous (Fig. 3). This variant was not detected in 212 ethnically
matched control chromosomes, and the possibility of neutral
polymorphism was excluded. A second homozygous missense
variant (c.458T>C, p.Ile153Thr) in exon 3 of CTSC was also
identiﬁed; however, it corresponded to a single nucleotide
polymorphism (rs217086) with a minor allele frequency of
>90% in the 1000 genome database, and was therefore not
likely to be pathogenic.
4. Discussion
With the recent advances in next-generation sequencing tech-
nologies, whole-exome analysis has signiﬁcantly improved
pathogenic variant identiﬁcation, especially in hereditary skin
disorders with inter- and intra-familial phenotypic variability
(Lai-Cheong and McGrath, 2011; Salam et al., 2014). In thecurrent study, we combined genome-wide homozygosity map-
ping with whole-exome analysis for a successful and efﬁcient
molecular diagnosis.
The PALS disease locus was ﬁrst mapped to 11q14 in 1997,
and 2 years later, the causative mutations in CTSC were iden-
tiﬁed (Fischer et al., 1997; Hart et al., 1999; Toomes et al.,
1999). Interestingly, CTSC involvement has been ruled out
in several PALS patients through traditional DNA sequencing,
despite establishing linkage to 11q14 (Hart et al., 2000a; Khan
et al., 2014). More recently, the mutation spectrum of PALS,
HMS, and AP1 phenotypes has been widely studied; however,
a clear genotype–phenotype correlation could not be estab-
lished. In an attempt to summarize the genotype–phenotype
correlation, a recent review outlined all the known mutations
in CTSC (Nagy et al., 2014). Only one is listed for the HMS
phenotype, while seven cause more than one phenotype,
including PALS (Nagy et al., 2014). Several polymorphisms
were associated with the PALS phenotype; however, in our
family, one of these polymorphisms (rs217086) was also
detected in unaffected healthy individuals.
Two missense mutations, including c.899G>A in an
affected sibling from one family and c.815G>C in affected
Figure 3 Mutation analysis of CTSC (c.899G>A).
Electropherogram of a single base-pair G>A substitution at
nucleotide 899 in an affected patient (A), a carrier parent (B), and
a wild-type unaffected individual (C).
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associated with the PALS phenotype in patients from Saudi
Arabia (Zhang et al., 2001). The mutation c.815G>C was
identiﬁed as possible evidence of the founder effect being pre-
sent in the four families, whose distant relationships were not
known (Zhang et al., 2001). Here we report further evidence of
the founder effect in CTSC from the same population. As the
clinical features of the c.899G>A mutation have not previ-
ously been clearly described, the current study included a
detailed clinical description of our patients who carried the
same mutation as previously reported (Zhang et al., 2001).
Our ﬁndings expand the knowledge on CTSC pathogenicity
in PALS, and will provide a basis for genotype–phenotype
correlations in this rare disorder.
5. Conclusions
This study describes the complete clinical and molecular
assessment of PALS in a consanguineous family of Saudi ori-
gin. Next generation sequencing has been widely adopted for
efﬁcient molecular diagnosis because of its precision and cost
effectiveness. The Saudi population is unique, and to date
there is no publically available reference genome database
for this population. Whole-exome sequencing may provide
better data for constructing reference databases in Saudi
Arabia, and may replace traditional methods of variant
detection.Conﬂicts of interest
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